PTC Acquisitions
PTC has acquired 3 companies and its latest acquisition was Censa Pharmaceuticals, Inc. on May 2020
COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Censa Pharmaceuticals, Inc.
May 2020
Source »$10M
Censa Pharmaceuticals develops and commercializes drugs for the treatment of phenylketonuria.
Agilis Biotherapeutics, Inc.
Jul 2018
Source »$200M
Agilis is a biotechnology company that engages in developing gene-based therapeutics for rare monogenic diseases that affect the central nervous system.
EMFLAZA
Mar 2017
Source »$140M
Emflaza focuses on developing drugs for the treatment of Duchenne muscular dystrophy disease.
Frequently Asked Questions about PTC
What companies did PTC acquire?
Companies acquired by PTC include Censa Pharmaceuticals, Agilis Biotherapeutics and EMFLAZAHow many acquisitions does PTC have?
PTC has acquired 3 companies including Censa Pharmaceuticals, Agilis Biotherapeutics and EMFLAZA.
How many acquisitions did PTC make in 2020?
In 2020 PTC acquired 1 companies including Censa Pharmaceuticals.